FDA published a final guidance entitled Communications From Firms to Health Care Providers Regarding Scientific Information ...
Final Guidance Further Expands Scope of Permissible Proactive Off-Label Communications - On January 6, 2025, FDA finalized ...
A Tennessee man admitted to creating and selling unapproved drugs for use in bodybuilding through his Kalispell business ...
A Tennessee man accused of creating and selling unapproved drugs for use in bodybuilding from his Kalispell business has ...
Dec 17 (Reuters) - The U.S. Food and Drug Administration said on Tuesday it has sent warning letters to four companies for selling unapproved versions of GLP-1 drugs including semaglutide and ...
According to the FDA, 1 each of the unapproved products were sold on the firm’s websites, Amazon shops, and social media ...
The two labels are very similar ... “Intravenous administration of the unapproved non-sterile topical Adrenalin® Chloride Solution (EPINEPHrine nasal solution, USP), instead of the approved ...